—
Preparation of the European Council meeting of 16-17 December 2021 - The EU's response to the global resurgence of Covid-19 and the new emerging Covid variants (debate)
The latest COVID variant omikron boosted the stock prices of Pfizer and Moderna considerably. Pfizer saw its share close 6.1 percent higher, about $17.5 billion in additional market value. Competitor Moderna even saw its shares increase by 21 percent. A virus variant such as . This is particularly cynical. After all, it is precisely Big Pharma's patents that make new variants more likely. Patents …